Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults with X-Linked Hypophosphatemia (XLH): A 3-Year Follow-Up of the XLH Disease Monitoring Program.
- DOI
- 10.1093/jbmr/zjag136
- Published
- 2026 Sep 23
- Container
- Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jbmr/zjag136,
title = {Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults with X-Linked Hypophosphatemia (XLH): A 3-Year Follow-Up of the XLH Disease Monitoring Program.},
author = {Ing SW and Bowden SA and Dahir KM and Florenzano P and Holm IA and Khan S and Levine MA and Moreira CA and Tabatabai L and Weber TJ and Tewari S and Johnson B and Vincent M and Patel J and Kotinkaduwa LN and Li Z and Ward LM and Imel EA and DMP Investigators},
year = {2026},
journal = {Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research},
doi = {10.1093/jbmr/zjag136},
url = {https://doi.org/10.1093/jbmr/zjag136}
}RIS
TY - JOUR TI - Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults with X-Linked Hypophosphatemia (XLH): A 3-Year Follow-Up of the XLH Disease Monitoring Program. AU - Ing SW AU - Bowden SA AU - Dahir KM AU - Florenzano P AU - Holm IA AU - Khan S AU - Levine MA AU - Moreira CA AU - Tabatabai L AU - Weber TJ AU - Tewari S AU - Johnson B AU - Vincent M AU - Patel J AU - Kotinkaduwa LN AU - Li Z AU - Ward LM AU - Imel EA AU - DMP Investigators PY - 2026 JO - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research DO - 10.1093/jbmr/zjag136 UR - https://doi.org/10.1093/jbmr/zjag136 ER -
APA
SW, I., SA, B., KM, D., P, F., IA, H., S, K., MA, L., CA, M., L, T., TJ, W., S, T., B, J., M, V., J, P., LN, K., Z, L., LM, W., EA, I., & Investigators, D. (2026). Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults with X-Linked Hypophosphatemia (XLH): A 3-Year Follow-Up of the XLH Disease Monitoring Program.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. https://doi.org/10.1093/jbmr/zjag136
Source records
- pubmed · retrieved 2026-09-25T11:58:25.036Z